Medical Marijuana Market size was over USD 15.97 billion in 2023 and is projected to reach USD 202.97 billion by 2036, witnessing around 21.6% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of medical marijuana is evaluated at USD 18.73 billion.
The increased acceptability of the drug as a medicine and for usage by adults is anticipated to aid in the growth of the market. The product is being widely accepted as a pharmaceutical medicine as it helps in the treatment of several diseases.
The market for medical marijuana is anticipated to expand as the medicine is used in several medical conditions, therapies, and chronic diseases. Moreover, the medicine is also used by adults to get rid of chronic and severe pain.
Growth Drivers
Challenges
Marijuana is a drug that can leave a negative impact on the health of a person if mishandled. This creates a threat to the market growth. The drug is not legalized everywhere. Further, it is a recreational drug and it can leave symptoms including altering the mind, addiction, and others if it is not used as prescribed by the doctors. Another hindrance to the market can be the regulations imposed by the government on the usage of the medicine.
Base Year |
2023 |
Forecast Year |
2024–2036 |
CAGR |
21.6% |
Base Year Market Size (2023) |
USD 15.97 billion |
Forecast Year Market Size (2036) |
USD 202.97 billion |
Regional Scope |
|
The medical marijuana market is segmented by end- user, by product, by application, and by region. On the basis of end user, the market is segmented into hospitals, clinics and others, and the segment for hospitals is anticipated to hold the leading market share as these institutions use the medicine to treat chronic diseases and for therapies as well. Moreover, the drug can only be used if there is a prescription in several regions.
Our in-depth analysis of the global market includes the following segments:
By End- user |
|
By Product |
|
Application |
|
On the basis of region-wise analysis, the medical marijuana market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The North America industry is expected to hold largest revenue share by 2036, as a result of legalization of the drug in several parts of the region and increased knowledge of the medicinal properties of the drug are anticipated to result in a high acceptance of the drug in this region. This may end up in the legalization of the drug in this region considering the medical benefits.
January 2, 2020: Tilray Inc. is a Canadian company which is headquartered in Toronto, and has operations in Australia, Portugal, Germany, and New Zealand. It deals in pharmaceutical and cannabis products. The company entered into an agreement with Canndoc Ltd. to export 2.5 tonnes of medical cannabis from Portugal to Israel to meet the rising demand. It was the first medical cannabis import allowed by Israel.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?